SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-007052
Filing Date
2020-06-29
Accepted
2020-06-29 09:00:44
Documents
3
Period of Report
2020-06-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbmg_8k.htm 8-K 52917
2 PRESS RELEASE cbmg_ex991.htm EX-99.1 11060
3 IMAGE cbmg_ex991000.jpg GRAPHIC 9061
  Complete submission text file 0001654954-20-007052.txt   77928
Mailing Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20878
Business Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20878 (301) 825 5320
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 20996029
SIC: 2836 Biological Products, (No Diagnostic Substances)